Onderzoeker
Tom Venken
- Disciplines:Biochemie en metabolisme, Systeembiologie, Medische biochemie en metabolisme
Affiliaties
- Biochemie, Moleculaire en Structurele Biologie (Afdeling)
Lid
Vanaf12 okt 2009 → 31 dec 2017
Publicaties
1 - 10 van 23
- PARP inhibitor predictive value of the Leuven HRD test compared with Myriad MyChoice CDx PLUS HRD on 468 ovarian cancer patients from the PAOLA-1/ENGOT-ov25 trial(2023)
Auteurs: Liselore Loverix, Ignace Vergote, Pieter Busschaert, Tom Venken, Bram Boeckx, Hilde Brems, Els Van Nieuwenhuysen, Thaïs Baert, Sileny Han, Patrick Neven, et al.
Pagina's: 131 - 139 - Transcription factor NKX2-1 drives serine and glycine synthesis addiction in cancer(2023)
Auteurs: Elien Heylen, Paulien Verstraete, Linde Van Aerschot, Tom Venken, David Nittner, Anne Uyttebroeck, Heidi Segers, Diether Lambrechts, Jan Cools, Kim De Keersmaecker, et al.
Pagina's: 1862 - 1878 - Multiomics and spatial mapping characterizes human CD8+T cell states in cancer(2023)
Auteurs: Stefan Naulaerts, Daniel Borras Morales, Julie Messiaen, Isaure Vanmeerbeek, Jenny Sprooten, Dena Panovska, Yannick Van Herck, Lendert Gelens, Tom Venken, Oliver Bechter, et al.
- Analysis of cell free DNA to predict outcome to Bevacizumab combination therapy in metastatic colorectal cancer patients(2023)
Auteurs: Tom Venken, Ingrid Arijs, Diether Lambrechts
- Nucleosome footprinting in plasma cell-free DNA for the pre-surgical diagnosis of ovarian cancer(2022)
Auteurs: Pieter Busschaert, Siel Olbrecht, An Coosemans, Wouter Froyman, Liselore Loverix, Els Van Nieuwenhuysen, Sileny Han, Toon Van Gorp, Tom Venken, Ruben Heremans, et al.
- DNA methylation-driven EMT is a common mechanism of resistance to various therapeutic agents in cancer(2020)
Auteurs: Eva Galle, Bernard Thienpont, Sarah Cappuyns, Tom Venken, Pieter Busschaert, Matthias Van Haele, Tania Roskams, Jos van Pelt, Chris Verslype, Jeroen Dekervel, et al.
- Enhancing the Performance of DNA Surface-Hybridization Biosensors through Target Depletion(2019)
Auteurs: Stefanos Nomidis, Tom Venken, Enrico Carlon
Pagina's: 12276 - 12283 - Molecular drug susceptibility testing and strain typing of tuberculosis by DNA hybridization(2019)
Auteurs: Tom Venken
- D-Peptides as inhibitors of PR3-membrane interactions(2018)
Auteurs: Ksenia Maximova, Tom Venken, Nathalie Reuter, Joanna Trylska
Pagina's: 458 - 466 - Computational Studies of the Active and Inactive Regulatory Domains of Response Regulator PhoP Using Molecular Dynamics Simulations(2017)
Auteurs: Xiaoyu Qing, Hans Steenackers, Tom Venken, Marc De Maeyer, Arnout Voet
Patenten
1 - 2 van 2
- Disease detection in liquid biopsies (Inventor)
- Disease detection in liquid biopsies (Inventor)